Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
EW: Edwards Lifesciences Corporation Stock Analysis | finqOS
Healthcare · Medical - Devices
The Story
EW
The Story
EW
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+8.6% / yr
Operating margin
28.1%
ROIC
10.6%
Financially safe
Stretched
Debt / equity
0.07×
Interest coverage
0.0×
Current ratio
4.42×
Valuation
Unrated
P/E ratio
49.5×
Edwards Lifesciences Corporation
EW
New York Stock Exchange
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Edwards Lifesciences Corporation
EW
New York Stock Exchange
·
USD
·
Closed
$86.07
−0.98%
$86.07
−$0.85 (0.98%)
52W Range
57th
pctl
Volume
0.77×
avg
Mkt Cap
49.56B
USD
P/E
49.5
TTM
Div Yield
–
ann
52W Range
57th
pctl
Volume
0.77×
avg
Market Cap
49.56B
USD
P/E Ratio
49.5
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings